This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Indiana Clinical and Translational Sciences Institute | |
|---|---|
| Name | Indiana Clinical and Translational Sciences Institute |
| Abbrev | ICTSI |
| Formation | 2008 |
| Type | Consortium |
| Headquarters | Indianapolis, Indiana |
| Region served | Indiana, United States |
| Leader title | Director |
| Leader name | David A. Brent |
| Affiliations | Indiana University School of Medicine, Purdue University, IUPUI, University of Notre Dame |
Indiana Clinical and Translational Sciences Institute
The Indiana Clinical and Translational Sciences Institute is a statewide consortium focused on accelerating biomedical research translation between laboratory discoveries and patient care, integrating partners across Indianapolis, Bloomington, Indiana, West Lafayette, Indiana, and South Bend, Indiana. Founded with support from the National Institutes of Health and modeled in part on other Clinical and Translational Science Award programs such as the Harvard Clinical and Translational Science Center and UCLA Clinical and Translational Science Institute, the institute connects investigators, clinicians, and community stakeholders from multiple academic and clinical institutions including Indiana University Health, Clarian Health Partners, Eskenazi Health, and regional partners.
The institute was established in response to the NIH's Clinical and Translational Science Award initiative, aligning with statewide efforts in Indiana University system modernization and collaborations among Purdue University and University of Notre Dame. Early milestones involved organizing cross-campus cores similar to those at University of Pennsylvania, Vanderbilt University, and Johns Hopkins University. Leadership transitions included faculty with prior appointments at Mayo Clinic, Cleveland Clinic, and Massachusetts General Hospital, and partnership expansion mirrored consortia models like the Translational Genomics Research Institute and Emory Clinical Translational Science Institute. Over time the institute incorporated community partners such as FQHCs and public health departments in Marion County, Indiana, while participating in multicenter networks like the National Patient-Centered Clinical Research Network and collaborations with the Centers for Disease Control and Prevention.
ICTSI's mission echoes NIH translational priorities exemplified by programs at NIH Clinical Center and aims to reduce the time from discovery at institutions like Purdue University and Indiana University School of Medicine to interventions used in settings including Riley Hospital for Children and Eskenazi Health. Objectives include strengthening workforce pipelines similar to initiatives at University of California, San Francisco, expanding clinical trial capacity like Duke Clinical Research Institute, and enhancing community-engaged research as practiced by Morehouse School of Medicine and University of New Mexico.
The governance integrates representatives from Indiana University School of Medicine, Purdue University, University of Notre Dame, IUPUI, and major health systems including Indiana University Health and Ascension Health. Oversight mechanisms draw on practices from Association of American Universities member institutions and incorporate advisory boards with experts from National Institutes of Health, Food and Drug Administration, and nonprofit organizations such as the Robert Wood Johnson Foundation and Gates Foundation. Committees mirror those at Dartmouth Institute and Stanford University clinical translational programs, covering regulatory affairs, finance, and scientific review.
Research programs span translational domains similar to centers at Mount Sinai Health System and Columbia University Irving Medical Center, including biomedical informatics, biostatistics, clinical trial design, and community-based participatory research as practiced at University of Washington. Core facilities include biorepositories, imaging suites comparable to Mayo Clinic resources, genomics and proteomics cores similar to Broad Institute partnerships, and regulatory support echoing infrastructure of FDA-linked centers. Collaborative projects have linked investigators from Rutgers University, University of Michigan, Northwestern University, Ohio State University, and Purdue University to tackle precision medicine initiatives inspired by All of Us Research Program and pharmacogenomics consortia such as the Clinical Pharmacogenetics Implementation Consortium.
Training programs mirror KL2 and TL1 career development frameworks at institutions like Yale School of Medicine and University of Chicago, offering mentored career development for clinicians and scientists affiliated with Indiana University School of Medicine, Purdue University, University of Notre Dame, and partner community organizations such as HealthNet and Neighborhood Health Clinics. Educational efforts include workshops on Good Clinical Practice modeled after Transcelerate Biopharma guidelines, community engagement strategies informed by CDC Community Health Worker frameworks, and partnerships with K–12 outreach programs in Indianapolis Public Schools and statewide health departments such as the Indiana State Department of Health.
Primary funding has included awards from the National Institutes of Health CTSA program, supplemented by grants from foundations such as the Robert Wood Johnson Foundation, collaborations with pharmaceutical companies including Eli Lilly and Company and biotechnology partners in the Indiana Biosciences Research Institute, and cooperative agreements with federal agencies including the Agency for Healthcare Research and Quality and Centers for Medicare & Medicaid Services. The institute has formed strategic alliances with regional hospitals like St. Vincent Indianapolis Hospital, research networks such as REDCap-using consortia, and academic collaborations with Purdue University College of Engineering and Indiana University Department of Medicine.
ICTSI-supported projects have included pragmatic clinical trials resembling those from PCORI, community health interventions partnered with Eskenazi Health and FQHCs, and data-sharing initiatives integrated into networks like PCORnet and SPOR-style collaborations. Notable efforts involve pediatric mental health research linked to Riley Hospital for Children, opioid harm-reduction partnerships with Indiana State Police and public health offices, and precision oncology pilot programs connected to Indiana University Melvin and Bren Simon Cancer Center and multicenter consortia such as NCI-designated cancer centers. The institute's cores have enabled translational advances comparable to those from Duke University School of Medicine and Broad Institute collaborations, contributing to publications and trials registered with ClinicalTrials.gov and influencing statewide healthcare initiatives recognized by organizations like the Indiana Economic Development Corporation.
Category:Medical research institutes in the United States